In cataract surgery, a 2.4 mm scleral incision is made using a 6 mm IOL, whereas a 3.0 mm scleral incision is made using a 7 mm IOL. In the case of cataract surgery alone, phacoemulsification was performed with Centurion (Alcon Laboratories, Inc., Fort Worth, TX, USA); in the case of phacovitrectomy, a 25-gauge pars plana vitrectomy with constellation (Alcon Laboratories, Inc.) was performed. The IOL was fixed intracapsular in all cases. The type of lenses used were XY-1® (Hoya, Tokyo, Japan), Clareon® (Alcon Laboratories, Inc.), YP2.2R® (Kowa, Tokyo, Japan), Tecnis Eyhans® Optiblue® (Johnson & Johnson Vision, Santa Ana, CA, USA) in 6 mm diameter lenses, and X-70® (Santen, Osaka, Japan) in 7 mm diameter lenses. The IOL features are shown in Table 1 . The phacovitrectomy procedure included: (1) core vitrectomy; (2) peripheral vitrectomy with compression of the sclera; (3) removal of the epiretinal membrane (ERM) and internal limiting membrane in necessary cases; and (4) replacement of 20% sulfur hexafluoride (SF6) in the macular hole (MH) or retinal detachment (RD), as necessary. Postoperatively, SF6-replaced patients were placed in the prone position for 1 week to 2 weeks.
Clareon
Manufactured by Alcon
Sourced in Japan
Clareon is a lab equipment product designed for optical and microscopy applications. It serves as a platform for various analysis and imaging techniques. The core function of Clareon is to provide reliable and precise data acquisition and processing capabilities to support scientific research and investigations.
Automatically generated - may contain errors
Lab products found in correlation
2 protocols using clareon
1
Cataract Surgery Techniques and Intraocular Lens Characteristics
2
Femtosecond Laser-Assisted Cataract Surgery
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
To maintain surgical consistency, femtosecond laser (FL) assisted cataract surgery (FLACS) was performed in all eyes using the LenSx platform (Alcon Laboratories, Inc.). The FL was used to undertake capsulotomy, lens fragmentation and astigmatic keratotomies. Strict criteria for suitability for FLACS was followed so that no recruited patients would be excluded from the trial (table 1). Astigmatic keratotomies were performed on patients with corneal astigmatism greater than 0.8 diopters (D) based on corneal topography. All operations were performed under a local anaesthetic (LA) unless clinically indicated otherwise. All outcomes' analysis was undertaken only on the first operated eye, except for PROMS data which was collected on bilateral cases. No other additional procedures were planned, other than the FL astigmatic keratotomies. Phacoemulsification was performed in all eyes using an activefluidics torsional phacoemulsification system (Centurion, Alcon Laboratories, Inc.). The IOL used for in-the-bag placement was randomized to either Clareon® (Alcon Laboratories, Inc.) or Tecnis® PCB00 (Johnson & Johnson Inc.). Operations were performed by six surgeons who had completed at least 30 FLACS procedures (NS, EA, DPSO, VW, MB, SR) before study commencement.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!